The effect of sub-epidermal moisture on pressure injury prevention strategies and incidence of pressure injuries: A feasibility pilot randomised controlled trial.

Localised oedema Pressure injury Pressure ulcer SEM Sub-epidermal moisture Visual skin assessment

Journal

Journal of tissue viability
ISSN: 0965-206X
Titre abrégé: J Tissue Viability
Pays: England
ID NLM: 9306822

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 18 04 2022
revised: 20 07 2022
accepted: 21 07 2022
pubmed: 8 8 2022
medline: 21 12 2022
entrez: 7 8 2022
Statut: ppublish

Résumé

Sub-epidermal moisture scanning (SEMS) is a novel point-of-care technology that measures localised oedema and detects early tissue damage that may develop into a pressure injury (PI). It provides objective data that may assist PI prevention (PIP) decision making. This study aimed to determine the feasibility of undertaking a definitive randomised controlled trial (RCT) to test the effectiveness of SEMS. This pilot RCT recruited medical and surgical patients at risk of developing a PI in one Australian hospital. All participants received routine PIP care and daily visual skin assessment to determine the presence of a PI. The intervention group also received daily SEMS. Clinical staff were told if the sub-epidermal moisture (SEM) value was abnormal but were not given advice for PIP. Blinding of patients, care staff and outcome assessors was not practical. Feasibility outcomes included recruitment, retention, intervention fidelity, and patient outcomes. Of 1185 patients screened prior to eligibility, 950 were excluded (80%); 235 were then assessed for eligibility and 160 met the inclusion criteria (68.1%); 100 were recruited (70.0%) and randomised and 99 completed the trial (intervention n = 50; control n = 49) with one person withdrawn due to inappropriate recruitment (100% retention). Of the 657 expected SEMS observations, 598 were completed (91% intervention fidelity). Only 34 of 454 (7.4%) patient outcome data points were missing. Most feasibility criteria were met, indicating a definitive trial to assess the effectiveness of SEMS in a medical-surgical patient population is realistic. However, recruitment may be resource intensive and require specific strategies.

Identifiants

pubmed: 35934637
pii: S0965-206X(22)00082-1
doi: 10.1016/j.jtv.2022.07.008
pii:
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Pagination

776-782

Informations de copyright

Copyright © 2022 Tissue Viability Society / Society of Tissue Viability. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Jill Campbell reports a relationship with Hartmann Pty Ltd that includes: consulting or advisory. Zena Moore reports a relationship with BBI Global Scientific Advisory Board that includes: board membership and consulting or advisory. Gary Allen reports a relationship with Australasian Human Research Ethics Consultancy Services that includes: employment. Fiona Coyer reports a relationship with Molnlycke Pty Ltd that includes: consulting or advisory. School of Nursing & Midwifery, RCSI, has a research collaboration with BBI.

Auteurs

Jill Campbell (J)

Centre of Research Excellence in Wiser Wound Care, Menzies Health Institute Queensland, Griffith University, Australia.

Wendy Chaboyer (W)

Centre of Research Excellence in Wiser Wound Care, Menzies Health Institute Queensland, Griffith University, Australia.

Georgia Tobiano (G)

Centre of Research Excellence in Wiser Wound Care, Menzies Health Institute Queensland, Griffith University and Gold Coast University Hospital, Gold Coast Health, Australia. Electronic address: G.Tobiano@griffith.edu.au.

Emma Harbeck (E)

Centre of Research Excellence in Wiser Wound Care, Menzies Health Institute Queensland, Griffith University, Australia.

Tracy Nowicki (T)

The Prince Charles Hospital, Australia.

Zena Moore (Z)

School of Nursing & Midwifery, Royal College of Surgeons in Ireland, University of Medicine, and Health Sciences, Ireland.

Gary Allen (G)

Office for Research, Griffith University, Australia.

Brigid Gillespie (B)

Centre of Research Excellence in Wiser Wound Care, Menzies Health Institute Queensland, Griffith University and Gold Coast University Hospital, Gold Coast Health, Australia.

Fiona Coyer (F)

School of Nursing, Queensland University of Technology and Intensive Care Services, Royal Brisbane and Women's Hospital, Metro North Health, Australia.

Rachel Walker (R)

School of Nursing and Midwifery, Menzies Health Institute Queensland, Griffith University, Division of Surgery, Princess Alexandra Hospital, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH